4/22
04:55 pm
kalv
Form 8-K KalVista Pharmaceuticals For: Apr 18
Low
Report
Form 8-K KalVista Pharmaceuticals For: Apr 18
4/22
04:37 pm
kalv
Form 4 KalVista Pharmaceuticals For: Apr 18 Filed by: Fairey William
Low
Report
Form 4 KalVista Pharmaceuticals For: Apr 18 Filed by: Fairey William
4/22
04:35 pm
kalv
Form 3 KalVista Pharmaceuticals For: Apr 18 Filed by: Fairey William
Low
Report
Form 3 KalVista Pharmaceuticals For: Apr 18 Filed by: Fairey William
4/1
04:15 pm
kalv
Form SC 13D/A KalVista Pharmaceuticals Filed by: TCG Crossover GP I, LLC
Low
Report
Form SC 13D/A KalVista Pharmaceuticals Filed by: TCG Crossover GP I, LLC
3/11
04:38 pm
kalv
Form 8-K KalVista Pharmaceuticals For: Mar 11
Medium
Report
Form 8-K KalVista Pharmaceuticals For: Mar 11
3/11
04:26 pm
kalv
Form 10-Q KalVista Pharmaceuticals For: Jan 31
Medium
Report
Form 10-Q KalVista Pharmaceuticals For: Jan 31
3/8
04:51 pm
kalv
Form 4 KalVista Pharmaceuticals For: Mar 06 Filed by: Palleiko Benjamin L
Medium
Report
Form 4 KalVista Pharmaceuticals For: Mar 06 Filed by: Palleiko Benjamin L
3/7
06:39 am
kalv
Form 8-K KalVista Pharmaceuticals For: Mar 06
Low
Report
Form 8-K KalVista Pharmaceuticals For: Mar 06
2/26
04:36 pm
kalv
Form SC 13G KalVista Pharmaceuticals Filed by: ADAGE CAPITAL PARTNERS GP, L.L.C.
Medium
Report
Form SC 13G KalVista Pharmaceuticals Filed by: ADAGE CAPITAL PARTNERS GP, L.L.C.
2/22
04:16 pm
kalv
Form 4 KalVista Pharmaceuticals For: Feb 20 Filed by: VHCP Co-Investment Holdings III, LLC
Neutral
Report
Form 4 KalVista Pharmaceuticals For: Feb 20 Filed by: VHCP Co-Investment Holdings III, LLC
2/22
01:23 pm
kalv
Form SC 13D/A KalVista Pharmaceuticals Filed by: Frazier Life Sciences Public Fund, L.P.
Low
Report
Form SC 13D/A KalVista Pharmaceuticals Filed by: Frazier Life Sciences Public Fund, L.P.
2/21
09:52 pm
kalv
Form 4 KalVista Pharmaceuticals For: Feb 17 Filed by: Feener Edward P.
Medium
Report
Form 4 KalVista Pharmaceuticals For: Feb 17 Filed by: Feener Edward P.
2/21
09:49 pm
kalv
Form 4 KalVista Pharmaceuticals For: Feb 17 Filed by: Yea Christopher
Medium
Report
Form 4 KalVista Pharmaceuticals For: Feb 17 Filed by: Yea Christopher
2/21
09:47 pm
kalv
Form 4 KalVista Pharmaceuticals For: Feb 17 Filed by: Palleiko Benjamin L
Medium
Report
Form 4 KalVista Pharmaceuticals For: Feb 17 Filed by: Palleiko Benjamin L
2/21
09:45 pm
kalv
Form 4 KalVista Pharmaceuticals For: Feb 17 Filed by: Audhya Paul K.
Medium
Report
Form 4 KalVista Pharmaceuticals For: Feb 17 Filed by: Audhya Paul K.
2/21
09:42 pm
kalv
Form 4 KalVista Pharmaceuticals For: Feb 17 Filed by: Crockett Thomas Andrew
Medium
Report
Form 4 KalVista Pharmaceuticals For: Feb 17 Filed by: Crockett Thomas Andrew
2/20
04:50 pm
kalv
Form SC 13D/A KalVista Pharmaceuticals Filed by: TCG Crossover GP I, LLC
Medium
Report
Form SC 13D/A KalVista Pharmaceuticals Filed by: TCG Crossover GP I, LLC
2/16
04:33 pm
kalv
Form 8-K KalVista Pharmaceuticals For: Feb 14
Medium
Report
Form 8-K KalVista Pharmaceuticals For: Feb 14
2/16
04:30 pm
kalv
Form 424B5 KalVista Pharmaceuticals
Medium
Report
Form 424B5 KalVista Pharmaceuticals
2/16
04:21 pm
kalv
Form 4 KalVista Pharmaceuticals For: Feb 14 Filed by: Palleiko Benjamin L
Medium
Report
Form 4 KalVista Pharmaceuticals For: Feb 14 Filed by: Palleiko Benjamin L
2/16
04:20 pm
kalv
Form 4 KalVista Pharmaceuticals For: Feb 14 Filed by: Crockett Thomas Andrew
Medium
Report
Form 4 KalVista Pharmaceuticals For: Feb 14 Filed by: Crockett Thomas Andrew
2/16
04:19 pm
kalv
Form 4 KalVista Pharmaceuticals For: Feb 14 Filed by: Feener Edward P.
Medium
Report
Form 4 KalVista Pharmaceuticals For: Feb 14 Filed by: Feener Edward P.
2/16
04:18 pm
kalv
Form 4 KalVista Pharmaceuticals For: Feb 14 Filed by: Yea Christopher
Medium
Report
Form 4 KalVista Pharmaceuticals For: Feb 14 Filed by: Yea Christopher
2/14
08:53 pm
kalv
Form SC 13G/A KalVista Pharmaceuticals Filed by: Venrock Healthcare Capital Partners III, L.P.
Medium
Report
Form SC 13G/A KalVista Pharmaceuticals Filed by: Venrock Healthcare Capital Partners III, L.P.
2/14
05:13 pm
kalv
Form 424B5 KalVista Pharmaceuticals
Medium
Report
Form 424B5 KalVista Pharmaceuticals